Aberrant localization of β-catenin correlates with overexpression of its target gene in human papillary thyroid cancer

被引:65
作者
Ishigaki, K
Namba, H
Nakashima, M
Nakayama, T
Mitsutake, N
Hayashi, T
Maeda, S
Ichinose, M
Kanematsu, T
机构
[1] Nagasaki Univ, Sch Med, Dept Mol Med, Atom Bomb Dis Inst, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Sch Med, Dept Mol Pathol,Tissue & Histopathol Sect, Atom Bomb Dis Inst,Div Sci Data Registry, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Sch Med, Dept Pathol, Nagasaki 8528523, Japan
[4] Nagasaki Univ, Sch Med, Dept Surg 2, Nagasaki 8528523, Japan
[5] Siebold Univ Nagasaki, Dept Nutr & Hlth Sci, Nagayo 8512195, Japan
关键词
D O I
10.1210/jc.87.7.3433
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alterations of the Wnt/beta-catenin signaling pathway are known to occur in mutations of the component genes such as APC, Axin, and beta-catenin, and play a pathogenetic role in tumorigenesis. Activated Wnt signaling stabilizes beta-catenin, which associates with T cell factor, resulting in transactivation of the downstream target genes including c-myc and cyclin D1. To investigate the involvement of Wnt/beta-catenin signaling pathway in thyroid tumorigenesis, we analyzed its activation and localization in 5 human thyroid cancer cell lines and 132 thyroid tumor tissue samples. Dislocalization of beta-catenin was observed in all cell lines. Constitutive activation of T cell factor in two of four thyroid cancer cell lines was observed using
引用
收藏
页码:3433 / 3440
页数:8
相关论文
共 46 条
[1]   Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1 [J].
Aoki, M ;
Hecht, A ;
Kruse, U ;
Kemler, R ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :139-144
[2]  
Barker N, 2000, BIOESSAYS, V22, P961
[3]  
Behrens J, 2000, ANN NY ACAD SCI, V910, P21
[4]  
BRABANT G, 1993, CANCER RES, V53, P4987
[5]   REGULATION OF THE CELL-CELL ADHESION PROTEIN, E-CADHERIN, IN DOG AND HUMAN THYROCYTES IN-VITRO [J].
BRABANT, G ;
HOANGVU, C ;
BEHRENDS, J ;
CETIN, Y ;
POTTER, E ;
DUMONT, JE ;
MAENHAUT, C .
ENDOCRINOLOGY, 1995, 136 (07) :3113-3119
[6]   PAPILLARY THYROID-CARCINOMA IN DANISH PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS [J].
BULOW, S ;
HOLM, NV ;
MELLEMGAARD, A .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1988, 3 (01) :29-31
[7]  
Cerrato A, 1998, J PATHOL, V185, P267
[8]   Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: Results from a European cooperative study [J].
Cetta, F ;
Montalto, G ;
Gori, M ;
Curia, MC ;
Cama, A ;
Olschwang, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :286-292
[9]   The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas [J].
Cetta, F ;
Chiappetta, G ;
Melillo, RM ;
Petracci, M ;
Montalto, G ;
Santoro, M ;
Fusco, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :1003-1006
[10]   A common human skin tumour is caused by activating mutations in β-catenin [J].
Chan, EF ;
Gat, U ;
McNiff, JM ;
Fuchs, E .
NATURE GENETICS, 1999, 21 (04) :410-413